SlideShare a Scribd company logo
Leprosy ( Hansen’s disease )
Turki M. Alanazi
objectives
• Definition.
• Overview.
• Modes of transmission
• Risk factors.
• Clinical features.
• Types/classifications.
• Diagnosis
• Pathogenesis
• Treatment.
• Complications.
• Epidemiology & preventions.
What is leprosy ?
• Leprosy (also known Hansen’s Disease) is an infectious disease
caused by Mycobacterium leprae which involves the skin and
peripheral nerves.
History of leprosy
• Leprosy was recognized in the ancient civilizations of
China, Egypt and India.
• The earliest documented account of leprosy is around
1550 B.C on Egyptian papyrus.
• Through out history, the badly affected have often been
hated by their communities and families.
CONT..
• Discovered by Gerhard Armauer Hansen in 1873.
Global Project on the History of Leprosy
http://www.leprosyhistory.org/graphics/gallery/hansen.jpg
Overview
• Key facts about
leprosy :
▫ Leprosy is a chronic
infectious disease
caused by an acid-fast,
rod-shaped bacillus,
Mycobacterium leprae.
▫ Unlike other
mycobacteria, it does
not grow in artificial
media or even in tissue
culture.
Scollard, DM et al. 2006. “The continuing challenges of leprosy.”
Clinical microbiology reviews 19, no. 2: 338-81.
Facts …
• M. leprae multiplies very slowly and the incubation period of
the disease is about five years. (average 3 yrs)
• Symptoms can take as long as 20 years to appear.
• Leprosy is not highly infectious.
• Leprosy is transmitted via droplets, from the nose and mouth,
during close and frequent contacts with untreated cases.
• Untreated, leprosy can cause progressive and permanent damage to
the skin, nerves, limbs and eyes.
Transmission
• The exact mechanism of transmission of leprosy is
not known.
• the most widely held belief is that the disease is
transmitted by contact between cases of leprosy and
healthy persons.
• & Transmission nasal discharges (droplets).
• Leprosy is known to occur at all ages ranging from
early infancy to very old age.
Risk Factors for Leprosy
• Close contact — Contacts of patients with leprosy have a higher risk
of developing leprosy than the general population
• People who live in the areas where leprosy is endemic
 (parts of India, China, Japan, Nepal, Egypt, and other areas) and
especially those people in constant physical contact with infected
people.
• Immunity – immunocompromised individuals are more
susceptible to infection.
• Genetic influences - There is some evidence that genetic defects in
the immune system may cause certain people to be more likely to
become infected (region q25 on chromosome 6).
• Armadillo exposure — Leprosy is enzootic in the nine-banded
armadillo
Classification of Leprosy
• Two types of classification :
▫ Skin smear result classification. ( WHO )
▫ Clinical classification. (Ridley Jopling)
Classification of Leprosy
▫ Skin smear result (WHO) classification :
• 1- Paucibacillary leprosy (PB) – few Bacilli;
• Two to five skin lesions with negative skin smear results at all
sites.
• 2. Multibacillary leprosy (MB);
• Any form of leprosy in which the patient shows positive
smears at any site
Classification of Leprosy
Clinical (Ridley Jopling) classification :
1. Indeterminate leprosy (IL)
2. Tuberculoid leprosy (TT)
3. Lepromatous leprosy (LL)
4. Borderline leprosy (BL)
 Borderline tuberculoid leprosy (BT)
 Borderline borderline leprosy (BB)
 Borderline lepromatous leprosy (BL)
Clinical features
1. Skin lesions, usually anaesthetic
 Hypopigmented or erythematus patch / plaque .
2. Complete / partial loss of sensation.
 Painless wounds or burns on the hands or feet
 Paresthesias: tingling or numbness in the hands or feet
 Diminished sensation or loss of sensation within skin patch(es)
3. Thickening of peripheral nerves.
4. Lumps or swelling on the earlobes or face.
5. Tender, enlarged peripheral nerves.
Indeterminate leprosy :Hypopigmented patch, sensation normal, no
palpable peripheral nerve and slit skin smear negative
Tuberculoid Leprosy: Annular, erythematous, anasthetic patch with well
defined and raised borders and SSS Negative.
Tuberculoid leprosy: Two hypopigmented patches, hypoasthetic well
defined borders, palpable peripheral nerve and SSS negative.
Borderline lepromatous leprosy (BL/MB)
Borderline lepromatous case showing borderline tuberculoid and
"punched- out" mid borderline lesions together with papular and
nodular lesions more typical of lepromatous disease.
A -Claw hand due to median and ulnar
nerve damage.
B- hands showing neurotrophic
atrophy.
Objectives
• Definition.
• Overview.
• Modes of transmission
• Risk factors.
• Clinical features.
• Types/classifications.
• Diagnosis
• Pathogenesis
• Treatment.
• Complications.
• Epidemiology & preventions.
Pathogenesis
• The areas most commonly affected by leprosy
are the superficial peripheral nerves , skin
,mucous membranes of the upper respiratory
tract, eyes , and tests
• Tissue damage is caused by the degree to which
cell-mediated immunity is expressed , the extent
of bacillary spread and multiplication ,
immunologic complication and nerve damage
Cont…
• M leprae is an obligate intracellular acid-fast
bacillus with unique ability to enter nerves
Diagnosis
• Diagnosis of leprosy is most commonly based
on the clinical sign and symptoms.
• In an endemic country or area, an individual
should be regarded as having leprosy if he or
she shows ONE of the following cardinal signs :
• skin lesion consistent with leprosy and with
definite sensory loss, with or without thickened
nerves
• positive skin smears
Cont…
• If you have a suspicious skin sore, your doctor
will remove a small sample of the abnormal skin
and send it to a laboratory to be examined. This
is called a skin biopsy . A skin smear test may
also be done. With paucibacillary leprosy, no
bacteria will be detected. In contrast, bacteria are
expected to be found on a skin smear test from a
person with multibacillary leprosy.
Treatment
• Common drugs
i. Dapson
ii. Refampicine
iii. Clofazimine
The combination of these three drugs
Is known as multi drug therapy (MDT)
Cont…
• 6 month regimen for Paucibacillary (PB)
Leprosy
oDapson 100 mg (daily)
oRefampicin 600 mg (monthly)
Cont…
• 12 month regimen for Multibacillary
(MB) Leprosy
oDapsone 100 mg (daily)
oRefampicin 600 mg (monthly)
oClofazimine 300 mg (monthly) or
o50 mg (daily)
complication
• disfigurement
• hair loss, particularly on the eyebrows and eyelashes
• muscle weakness
• permanent nerve damage in the arms and legs
• inability to use the hands and feet
• Nosebleeds
• iritis (inflammation of the iris of the eye), glaucoma
(an eye disease that causes damage to the optic
nerve), and blindness
• Infertility
• kidney failure
References
• WHO.
• UPTODATE.
• Kumar & Clarks clinical medicine.

More Related Content

What's hot

Basics Of Leprosy ( PATHOGENESIS)
Basics Of Leprosy ( PATHOGENESIS)Basics Of Leprosy ( PATHOGENESIS)
Basics Of Leprosy ( PATHOGENESIS)
MAYANK ,MEHENDIRATTA
 
Leprosy by dr. alteiob yousif
Leprosy by dr. alteiob yousifLeprosy by dr. alteiob yousif
Leprosy by dr. alteiob yousifAlteib Yousif
 
Classification of leprosy
Classification of leprosyClassification of leprosy
Classification of leprosykeshavapavan
 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLESYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
PARUL UNIVERSITY
 
Leprosy (Hansen's Disease)
Leprosy (Hansen's Disease) Leprosy (Hansen's Disease)
Leprosy (Hansen's Disease)
KULDEEP VYAS
 
Ankylosing spondylitis,Causes,symptoms,diagnosis,management
Ankylosing spondylitis,Causes,symptoms,diagnosis,managementAnkylosing spondylitis,Causes,symptoms,diagnosis,management
Ankylosing spondylitis,Causes,symptoms,diagnosis,management
Dr.Md.Monsur Rahman
 
Gout
GoutGout
Ankylosing spondylitis
Ankylosing spondylitisAnkylosing spondylitis
Ankylosing spondylitisAbigail Abalos
 
Scleroderma
SclerodermaScleroderma
Scleroderma
Muhammad Eimaduddin
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
Sapeedeh Afzal
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
Siva Nanda Reddy
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
swathisravani
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
swathisravani
 
Leprosy & syphilis
Leprosy & syphilisLeprosy & syphilis
Leprosy & syphilis
Dr. Varughese George
 
Lepra reactions
Lepra reactionsLepra reactions
Lepra reactions
DR RML DELHI
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
Kirsha K S
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
Harsh shaH
 

What's hot (20)

Basics Of Leprosy ( PATHOGENESIS)
Basics Of Leprosy ( PATHOGENESIS)Basics Of Leprosy ( PATHOGENESIS)
Basics Of Leprosy ( PATHOGENESIS)
 
Leprosy
LeprosyLeprosy
Leprosy
 
Leprosy by dr. alteiob yousif
Leprosy by dr. alteiob yousifLeprosy by dr. alteiob yousif
Leprosy by dr. alteiob yousif
 
Classification of leprosy
Classification of leprosyClassification of leprosy
Classification of leprosy
 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLESYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
 
Leprosy (Hansen's Disease)
Leprosy (Hansen's Disease) Leprosy (Hansen's Disease)
Leprosy (Hansen's Disease)
 
Ankylosing spondylitis,Causes,symptoms,diagnosis,management
Ankylosing spondylitis,Causes,symptoms,diagnosis,managementAnkylosing spondylitis,Causes,symptoms,diagnosis,management
Ankylosing spondylitis,Causes,symptoms,diagnosis,management
 
Gout
GoutGout
Gout
 
Gout
GoutGout
Gout
 
Ankylosing spondylitis
Ankylosing spondylitisAnkylosing spondylitis
Ankylosing spondylitis
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Syphilis
SyphilisSyphilis
Syphilis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Leprosy & syphilis
Leprosy & syphilisLeprosy & syphilis
Leprosy & syphilis
 
Lepra reactions
Lepra reactionsLepra reactions
Lepra reactions
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 

Viewers also liked

LEPROSY presentation pptx
LEPROSY  presentation pptxLEPROSY  presentation pptx
LEPROSY presentation pptx
MUSHTAQ AHMED
 
Leprosy for undergraduate medical students
Leprosy for undergraduate medical studentsLeprosy for undergraduate medical students
Leprosy for undergraduate medical students
Ali Gargoom
 
Leprosy power point presentation
Leprosy power point presentationLeprosy power point presentation
Leprosy power point presentationkharam ngati
 

Viewers also liked (6)

Leprosy
LeprosyLeprosy
Leprosy
 
LEPROSY presentation pptx
LEPROSY  presentation pptxLEPROSY  presentation pptx
LEPROSY presentation pptx
 
Leprosy
LeprosyLeprosy
Leprosy
 
Leprosy for undergraduate medical students
Leprosy for undergraduate medical studentsLeprosy for undergraduate medical students
Leprosy for undergraduate medical students
 
Leprosy power point presentation
Leprosy power point presentationLeprosy power point presentation
Leprosy power point presentation
 
Leprosy
LeprosyLeprosy
Leprosy
 

Similar to Leprosy ( hansen’s disease )

LEPROSY.ppt
LEPROSY.pptLEPROSY.ppt
LEPROSY.ppt
SardarAwais4
 
Leprosy
LeprosyLeprosy
Leprosy
Jack Frost
 
Leprosy
LeprosyLeprosy
Hansens disease
Hansens diseaseHansens disease
Hansens disease
SUMESH KUMAR DASH
 
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptxLEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
TheivaAmirthan
 
EPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSYEPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSY
MAHESWARI JAIKUMAR
 
EPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSYEPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSY
MAHESWARI JAIKUMAR
 
leprosy management of leprosy nursing students
leprosy management of leprosy nursing studentsleprosy management of leprosy nursing students
leprosy management of leprosy nursing students
REKHA DEHARIYA
 
Leprosy 2
Leprosy 2Leprosy 2
Leprosy 2
DR. ANKUR KUMAR
 
leprosy for medical students
leprosy for medical studentsleprosy for medical students
leprosy for medical students
NCRIMS, Meerut
 
Mycobacterium leprae
Mycobacterium lepraeMycobacterium leprae
Mycobacterium lepraeGovind Sah
 
Leprosy
LeprosyLeprosy
Leprosy
Rajnee Mishra
 
Leprosy (Hansen’s Disease).pptx
Leprosy (Hansen’s Disease).pptxLeprosy (Hansen’s Disease).pptx
Leprosy (Hansen’s Disease).pptx
Khem21
 
Leprosy Department of Physiotherapy, SHUATS, Prayagraj
Leprosy Department of Physiotherapy, SHUATS, PrayagrajLeprosy Department of Physiotherapy, SHUATS, Prayagraj
Leprosy Department of Physiotherapy, SHUATS, Prayagraj
Surabhi Srivastava
 
Leprosy_٢.pptx
Leprosy_٢.pptxLeprosy_٢.pptx
Leprosy_٢.pptx
bhmMhmm
 
M leprae
M lepraeM leprae
Leprosy - Dermatology
Leprosy - DermatologyLeprosy - Dermatology
Leprosy - Dermatology
Nihal Yuzbasheva
 
01 ahmed omar leprosy -last edition
01 ahmed omar    leprosy -last edition01 ahmed omar    leprosy -last edition
01 ahmed omar leprosy -last edition
Ahmed Omar
 
Leprosy.pptx
Leprosy.pptxLeprosy.pptx
Leprosy.pptx
SridharA49
 

Similar to Leprosy ( hansen’s disease ) (20)

LEPROSY.ppt
LEPROSY.pptLEPROSY.ppt
LEPROSY.ppt
 
Leprosy
LeprosyLeprosy
Leprosy
 
Leprosy
LeprosyLeprosy
Leprosy
 
Leprosy
LeprosyLeprosy
Leprosy
 
Hansens disease
Hansens diseaseHansens disease
Hansens disease
 
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptxLEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
LEPROSYLEPROSYLEPROSY talk 14Sept2022.pptx
 
EPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSYEPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSY
 
EPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSYEPIDEMIOLOGY OF LEPROSY
EPIDEMIOLOGY OF LEPROSY
 
leprosy management of leprosy nursing students
leprosy management of leprosy nursing studentsleprosy management of leprosy nursing students
leprosy management of leprosy nursing students
 
Leprosy 2
Leprosy 2Leprosy 2
Leprosy 2
 
leprosy for medical students
leprosy for medical studentsleprosy for medical students
leprosy for medical students
 
Mycobacterium leprae
Mycobacterium lepraeMycobacterium leprae
Mycobacterium leprae
 
Leprosy
LeprosyLeprosy
Leprosy
 
Leprosy (Hansen’s Disease).pptx
Leprosy (Hansen’s Disease).pptxLeprosy (Hansen’s Disease).pptx
Leprosy (Hansen’s Disease).pptx
 
Leprosy Department of Physiotherapy, SHUATS, Prayagraj
Leprosy Department of Physiotherapy, SHUATS, PrayagrajLeprosy Department of Physiotherapy, SHUATS, Prayagraj
Leprosy Department of Physiotherapy, SHUATS, Prayagraj
 
Leprosy_٢.pptx
Leprosy_٢.pptxLeprosy_٢.pptx
Leprosy_٢.pptx
 
M leprae
M lepraeM leprae
M leprae
 
Leprosy - Dermatology
Leprosy - DermatologyLeprosy - Dermatology
Leprosy - Dermatology
 
01 ahmed omar leprosy -last edition
01 ahmed omar    leprosy -last edition01 ahmed omar    leprosy -last edition
01 ahmed omar leprosy -last edition
 
Leprosy.pptx
Leprosy.pptxLeprosy.pptx
Leprosy.pptx
 

More from Turki AlAnazi

BRUE.pdf
BRUE.pdfBRUE.pdf
BRUE.pdf
Turki AlAnazi
 
Rapid Sequence Intubation (RSI).pptx
Rapid Sequence Intubation (RSI).pptxRapid Sequence Intubation (RSI).pptx
Rapid Sequence Intubation (RSI).pptx
Turki AlAnazi
 
Otitis Media.pdf
Otitis Media.pdfOtitis Media.pdf
Otitis Media.pdf
Turki AlAnazi
 
Anaphylaxis.pptx
Anaphylaxis.pptxAnaphylaxis.pptx
Anaphylaxis.pptx
Turki AlAnazi
 
Peripheral neuropathy objective 3 (cts)
Peripheral neuropathy objective 3 (cts)Peripheral neuropathy objective 3 (cts)
Peripheral neuropathy objective 3 (cts)
Turki AlAnazi
 
Malaria
MalariaMalaria
Malaria
Turki AlAnazi
 
Fetal age & gender determination.
Fetal age & gender determination.Fetal age & gender determination.
Fetal age & gender determination.
Turki AlAnazi
 
Mammalian bites
Mammalian bitesMammalian bites
Mammalian bites
Turki AlAnazi
 

More from Turki AlAnazi (8)

BRUE.pdf
BRUE.pdfBRUE.pdf
BRUE.pdf
 
Rapid Sequence Intubation (RSI).pptx
Rapid Sequence Intubation (RSI).pptxRapid Sequence Intubation (RSI).pptx
Rapid Sequence Intubation (RSI).pptx
 
Otitis Media.pdf
Otitis Media.pdfOtitis Media.pdf
Otitis Media.pdf
 
Anaphylaxis.pptx
Anaphylaxis.pptxAnaphylaxis.pptx
Anaphylaxis.pptx
 
Peripheral neuropathy objective 3 (cts)
Peripheral neuropathy objective 3 (cts)Peripheral neuropathy objective 3 (cts)
Peripheral neuropathy objective 3 (cts)
 
Malaria
MalariaMalaria
Malaria
 
Fetal age & gender determination.
Fetal age & gender determination.Fetal age & gender determination.
Fetal age & gender determination.
 
Mammalian bites
Mammalian bitesMammalian bites
Mammalian bites
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Leprosy ( hansen’s disease )

  • 1. Leprosy ( Hansen’s disease ) Turki M. Alanazi
  • 2. objectives • Definition. • Overview. • Modes of transmission • Risk factors. • Clinical features. • Types/classifications. • Diagnosis • Pathogenesis • Treatment. • Complications. • Epidemiology & preventions.
  • 3. What is leprosy ? • Leprosy (also known Hansen’s Disease) is an infectious disease caused by Mycobacterium leprae which involves the skin and peripheral nerves.
  • 4. History of leprosy • Leprosy was recognized in the ancient civilizations of China, Egypt and India. • The earliest documented account of leprosy is around 1550 B.C on Egyptian papyrus. • Through out history, the badly affected have often been hated by their communities and families.
  • 5. CONT.. • Discovered by Gerhard Armauer Hansen in 1873. Global Project on the History of Leprosy http://www.leprosyhistory.org/graphics/gallery/hansen.jpg
  • 6. Overview • Key facts about leprosy : ▫ Leprosy is a chronic infectious disease caused by an acid-fast, rod-shaped bacillus, Mycobacterium leprae. ▫ Unlike other mycobacteria, it does not grow in artificial media or even in tissue culture. Scollard, DM et al. 2006. “The continuing challenges of leprosy.” Clinical microbiology reviews 19, no. 2: 338-81.
  • 7. Facts … • M. leprae multiplies very slowly and the incubation period of the disease is about five years. (average 3 yrs) • Symptoms can take as long as 20 years to appear. • Leprosy is not highly infectious. • Leprosy is transmitted via droplets, from the nose and mouth, during close and frequent contacts with untreated cases. • Untreated, leprosy can cause progressive and permanent damage to the skin, nerves, limbs and eyes.
  • 8. Transmission • The exact mechanism of transmission of leprosy is not known. • the most widely held belief is that the disease is transmitted by contact between cases of leprosy and healthy persons. • & Transmission nasal discharges (droplets). • Leprosy is known to occur at all ages ranging from early infancy to very old age.
  • 9. Risk Factors for Leprosy • Close contact — Contacts of patients with leprosy have a higher risk of developing leprosy than the general population • People who live in the areas where leprosy is endemic  (parts of India, China, Japan, Nepal, Egypt, and other areas) and especially those people in constant physical contact with infected people. • Immunity – immunocompromised individuals are more susceptible to infection. • Genetic influences - There is some evidence that genetic defects in the immune system may cause certain people to be more likely to become infected (region q25 on chromosome 6). • Armadillo exposure — Leprosy is enzootic in the nine-banded armadillo
  • 10. Classification of Leprosy • Two types of classification : ▫ Skin smear result classification. ( WHO ) ▫ Clinical classification. (Ridley Jopling)
  • 11. Classification of Leprosy ▫ Skin smear result (WHO) classification : • 1- Paucibacillary leprosy (PB) – few Bacilli; • Two to five skin lesions with negative skin smear results at all sites. • 2. Multibacillary leprosy (MB); • Any form of leprosy in which the patient shows positive smears at any site
  • 12. Classification of Leprosy Clinical (Ridley Jopling) classification : 1. Indeterminate leprosy (IL) 2. Tuberculoid leprosy (TT) 3. Lepromatous leprosy (LL) 4. Borderline leprosy (BL)  Borderline tuberculoid leprosy (BT)  Borderline borderline leprosy (BB)  Borderline lepromatous leprosy (BL)
  • 13.
  • 14. Clinical features 1. Skin lesions, usually anaesthetic  Hypopigmented or erythematus patch / plaque . 2. Complete / partial loss of sensation.  Painless wounds or burns on the hands or feet  Paresthesias: tingling or numbness in the hands or feet  Diminished sensation or loss of sensation within skin patch(es) 3. Thickening of peripheral nerves. 4. Lumps or swelling on the earlobes or face. 5. Tender, enlarged peripheral nerves.
  • 15. Indeterminate leprosy :Hypopigmented patch, sensation normal, no palpable peripheral nerve and slit skin smear negative
  • 16. Tuberculoid Leprosy: Annular, erythematous, anasthetic patch with well defined and raised borders and SSS Negative.
  • 17. Tuberculoid leprosy: Two hypopigmented patches, hypoasthetic well defined borders, palpable peripheral nerve and SSS negative.
  • 18.
  • 19.
  • 20. Borderline lepromatous leprosy (BL/MB) Borderline lepromatous case showing borderline tuberculoid and "punched- out" mid borderline lesions together with papular and nodular lesions more typical of lepromatous disease.
  • 21. A -Claw hand due to median and ulnar nerve damage. B- hands showing neurotrophic atrophy.
  • 22. Objectives • Definition. • Overview. • Modes of transmission • Risk factors. • Clinical features. • Types/classifications. • Diagnosis • Pathogenesis • Treatment. • Complications. • Epidemiology & preventions.
  • 23. Pathogenesis • The areas most commonly affected by leprosy are the superficial peripheral nerves , skin ,mucous membranes of the upper respiratory tract, eyes , and tests • Tissue damage is caused by the degree to which cell-mediated immunity is expressed , the extent of bacillary spread and multiplication , immunologic complication and nerve damage
  • 24. Cont… • M leprae is an obligate intracellular acid-fast bacillus with unique ability to enter nerves
  • 25. Diagnosis • Diagnosis of leprosy is most commonly based on the clinical sign and symptoms. • In an endemic country or area, an individual should be regarded as having leprosy if he or she shows ONE of the following cardinal signs : • skin lesion consistent with leprosy and with definite sensory loss, with or without thickened nerves • positive skin smears
  • 26. Cont… • If you have a suspicious skin sore, your doctor will remove a small sample of the abnormal skin and send it to a laboratory to be examined. This is called a skin biopsy . A skin smear test may also be done. With paucibacillary leprosy, no bacteria will be detected. In contrast, bacteria are expected to be found on a skin smear test from a person with multibacillary leprosy.
  • 27.
  • 28. Treatment • Common drugs i. Dapson ii. Refampicine iii. Clofazimine The combination of these three drugs Is known as multi drug therapy (MDT)
  • 29. Cont… • 6 month regimen for Paucibacillary (PB) Leprosy oDapson 100 mg (daily) oRefampicin 600 mg (monthly)
  • 30. Cont… • 12 month regimen for Multibacillary (MB) Leprosy oDapsone 100 mg (daily) oRefampicin 600 mg (monthly) oClofazimine 300 mg (monthly) or o50 mg (daily)
  • 31. complication • disfigurement • hair loss, particularly on the eyebrows and eyelashes • muscle weakness • permanent nerve damage in the arms and legs • inability to use the hands and feet • Nosebleeds • iritis (inflammation of the iris of the eye), glaucoma (an eye disease that causes damage to the optic nerve), and blindness • Infertility • kidney failure
  • 32.
  • 33. References • WHO. • UPTODATE. • Kumar & Clarks clinical medicine.